Lung Cancer Research Foundation (LCRF):

Leading Edge Research Grant Program in Lung Cancer (LOI):  Innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, early detection, disparities, and social determinants of health research. For early-career and mid-career investigators with less than ten years experience since their initial faculty appointment. Funding: up to $150K for 2 years (No overhead, Non-profit)   

Early Detection and Pre-Neoplasia in Lung Cancer (LOI):  Identifying, characterizing, and developing approaches and techniques that will allow early detection and/or prevention of lung cancer and gaining insight into preneoplastic processes in the lungs. Areas of interest include: Identification and characterization of new biomarkers for NSCLC and SCLC / Liquid biopsy assays and related techniques / Improvements in risk stratifying patients for screening / Development of predictive, diagnostic, or prognostic biomarkers / Genomic and histological approaches to improve early detection in tissue samples / Novel imaging modalities to identify and risk stratify pre-neoplastic lesions / Studies of pre-neoplasia and progression to lung neoplasia that may inform prevention strategies / Development of pathways to increase uptake and utilization of lung cancer screening.  Intended to support early-stage researchers and faculty within the first 10 years of their appointment. Funding: up to $150K for 2 years (No overhead, Non-profit)   

Understanding Resistance in Lung Cancer (LOI):  Understanding the development, prevention, and therapy of resistance by supporting projects that are identifying, characterizing, treating or preventing resistance to therapies in lung tumor cells, tissues, mouse models, and/or patients. Funding: up to $150K for 2 years (No overhead, Non-profit)   

www.lungcancerresearchfoundation.org/research/funding-opportunities-2023